First Light Asset Management, LLC

Add to watchlist

$202 Million is the total value of First Light Asset Management, LLC's 62 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 0.0% .

All

		Value		Shares		↓ Weighting
HUM	HUMANA INCcs	$634,000	-6.4%	3,540	0.0%	0.31%	-1.9%
ANTM	ANTHEM INC COMcs	$573,000	-14.7%	4,095	0.0%	0.28%	-10.4%
AET	AETNA INC NEWcs	$571,000	-14.1%	5,215	0.0%	0.28%	-9.9%
ENDP	ENDO INTL PLCcs	$565,000	-13.1%	8,161	0.0%	0.28%	-8.8%
NVS	NOVARTIS A Gadr	$558,000	-6.5%	6,070	0.0%	0.28%	-1.8%
AGN	ALLERGAN PLC SHScs	$553,000	-10.5%	2,035	0.0%	0.27%	-6.2%
UTHR	UNITED THERAPEUTICS CORP DELcs	$501,000	-24.5%	3,820	0.0%	0.25%	-20.8%
BMY	BRISTOL MYERS SQUIBB COcs	$491,000	-11.1%	8,290	0.0%	0.24%	-6.5%
CELG	CELGENE CORPcs	$463,000	-6.5%	4,280	0.0%	0.23%	-1.7%
LLY	LILLY ELI AND COcs	$460,000	+0.2%	5,495	0.0%	0.23%	+5.1%
BDX	BECTON DICKINSON AND COcs	$450,000	-6.4%	3,395	0.0%	0.22%	-1.8%
STE	STERIS CORPcs	$411,000	+0.7%	6,330	0.0%	0.20%	+5.7%
MYL	MYLAN N Vcs	$394,000	-40.6%	9,775	0.0%	0.20%	-37.5%
STJ	ST JUDE MED INCcs	$382,000	-13.6%	6,055	0.0%	0.19%	-9.1%
JNJ	JOHNSON AND JOHNSONcs	$357,000	-4.0%	3,820	0.0%	0.18%	+0.6%
PFE	PFIZER INCcs	$330,000	-6.5%	10,520	0.0%	0.16%	-1.8%
MRK	MERCK N CO INC NEWcs	$326,000	-13.3%	6,610	0.0%	0.16%	-9.0%
AMGN	AMGEN INCcs	$322,000	-10.1%	2,330	0.0%	0.16%	-5.4%
MYGN	MYRIAD GENETICS INCcs	$293,000	+10.2%	7,820	0.0%	0.14%	+16.0%
SNY	SANOFI-SYNTHELABOadr	$270,000	-3.9%	5,680	0.0%	0.13%	+0.8%
CYH	COMMUNITY HEALTH SYS INC NEWcs	$263,000	-32.0%	6,145	0.0%	0.13%	-28.6%
BIO	BIO RAD LABS INCcs	$225,000	-10.7%	1,675	0.0%	0.11%	-6.7%

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2015-11-16

Signatures

The EDGAR filing(s) were signed by:

Brett T. Johnson — Member, Senior Research Analyst, & Chief Compliance Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ATRICURE INC	40	Q3 2023	9.7%
NEOGENOMICS INC	40	Q3 2023	10.6%
SANOFI-SYNTHELABO	40	Q3 2023	1.9%
JOHNSON & JOHNSON	40	Q3 2023	0.3%
PFIZER INC	39	Q2 2023	0.9%
BIOMARIN PHARMACEUTICAL INC	36	Q3 2023	1.6%
OMNICELL INC	33	Q3 2023	7.7%
QUIDEL CORP	33	Q4 2021	3.7%
NOVARTIS AG-SPONSORED ADR	33	Q3 2023	0.4%
MODEL N INC	30	Q3 2023	9.0%

View First Light Asset Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

First Light Asset Management, LLC Q3 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
REATA PHARMACEUTICALS INC	May 15, 2023	1,290,193	3.9%
Axogen, Inc.	February 03, 2023	1,942,270	4.6%
MODEL N, INC.	February 03, 2023	1,845,134	4.9%
MEI Pharma, Inc.^{Sold out}	May 31, 2022	0	0.0%
PROTHENA CORP PUBLIC LTD CO	March 01, 2022	1,805,038	3.9%
Intersect ENT, Inc.	February 14, 2022	1,375,210	4.1%
SeaSpine Holdings Corp	February 14, 2022	6,847,707	18.8%
Oxford Immunotec Global PLC^{Sold out}	February 10, 2021	0	0.0%
ENDOLOGIX INC /DE/	February 14, 2020	816,236	4.6%
Nuvectra Corp^{Sold out}	February 14, 2020	0	0.0%

View First Light Asset Management, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2024-06-10
SC 13G/A	2024-06-10
13F-HR	2024-05-15
SC 13D/A	2024-04-09
4	2024-04-08
13F-HR	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G	2024-02-14
SC 13G	2024-02-14

View First Light Asset Management, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export First Light Asset Management, LLC's holdings